Non-neuronal cell responses differ between normal and Down syndrome developing brains

International Journal of Developmental Neuroscience

Volumn 31, Issue 8, 2013, Pages 796-803

  Kanaumi, Takeshi ^a,b,c   Milenkovic, Ivan ^a   Adle Biassette, Homa ^d,e,f   Aronica, Eleonora ^g,h,i   Kovacs, Gabor G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Nakatsu Municipal Hospital   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d HÔPITAL LARIBOISIÈRE   (France)

^e INSERM   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g University of The Netherlands   (Netherlands)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

CD68; Fetus; GFAP; HLA DR; Human; Olig2; TPPP p25

Indexed keywords

CD68 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DR ANTIGEN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN P25;

ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN REGION; CELL COUNT; CELL DENSITY; CLINICAL ARTICLE; DEVELOPMENTAL STAGE; DOWN SYNDROME; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MACROGLIA; MACROPHAGE; MALE; MENTAL DEFICIENCY; MICROGLIA; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; SUBICULUM; TEMPORAL LOBE; WHITE MATTER;

CD68; FETUS; GFAP; HLA-DR; HUMAN; OLIG2; TPPP/P25;

ANALYSIS OF VARIANCE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; CELL COUNT; DOWN SYNDROME; FEMALE; FETUS; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA-DR ANTIGENS; HUMANS; MACROPHAGES; MALE; NERVE TISSUE PROTEINS; NEUROGLIA; PREGNANCY;

EID: 84886454671     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.09.011     Document Type: Article

References (59)

1. Abraham H., Vincze A., Veszpremi B., Kravjak A., Gomori E., Kovacs G.G., Seress L. Impaired myelination of the human hippocampal formation in Down syndrome. Int. J. Dev. Sci. 2012, 30:147-158.
2. Adle-Biassette H., Verney C., Peoc'h K., Dauge M.C., Razavi F., Choudat L., Gressens P., Budka H., Henin D. Immunohistochemical expression of prion protein (PrPC) in the human forebrain during development. J. Neuropathol. Exp. Neurol. 2006, 65:698-706.
3. Bayer S.A., Altman J. Atlas of Human Central Nervous System Development 2005, CRC Press, Boca Raton.
4. Bechmann I., Kwidzinski E., Kovac A.D., Simburger E., Horvath T., Gimsa U., Dirnagl U., Priller J., Nitsch R. Turnover of rat brain perivascular cells. Exp. Neurol. 2001, 168:242-249.
5. Bechmann I., Priller J., Kovac A., Bontert M., Wehner T., Klett F.F., Bohsung J., Stuschke M., Dirnagl U., Nitsch R. Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur. J. Neurosci. 2001, 14:1651-1658.
6. Becker L., Mito T., Takashima S., Onodera K. Growth and development of the brain in Down syndrome. Prog. Clin. Biol. Res. 1991, 373:133-152.
7. Cai J., Chen Y., Cai W.H., Hurlock E.C., Wu H., Kernie S.G., Parada L.F., Lu Q.R. A crucial role for Olig2 in white matter astrocyte development. Development 2007, 134:1887-1899.
8. Chakrabarti L., Best T.K., Cramer N.P., Carney R.S., Isaac J.T., Galdzicki Z., Haydar T.F. Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat. Neurosci. 2010, 13:927-934.
9. Chapman R.S., Hesketh L.J. Behavioral phenotype of individuals with Down syndrome. Ment. Ret. Dev. Dis. Res. Rev. 2000, 6:84-95.
10. Contestabile A., Fila T., Ceccarelli C., Bonasoni P., Bonapace L., Santini D., Bartesaghi R., Ciani E. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 2007, 17:665-678.
11. Dalmau I., Finsen B., Tonder N., Zimmer J., Gonzalez B., Castellano B. Development of microglia in the prenatal rat hippocampus. J. Comp. Neurol. 1997, 377:70-84.
12. Eroglu C., Barres B.A. Regulation of synaptic connectivity by glia. Nature 2010, 468:223-231.
13. Fukuda S., Kondo T., Takebayashi H., Taga T. Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway. Cell. Death. Diff. 2004, 11:196-202.
14. Gabay L., Lowell S., Rubin L.L., Anderson D.J. Deregulation of dorsoventral patterning by FGF confers trilineage differentiation capacity on CNS stem cells in vitro. Neuron 2003, 40:485-499.
15. Golden J.A., Hyman B.T. Development of the superior temporal neocortex is anomalous in trisomy 21. J. Neuropathol. Exp. Neurol. 1994, 53:513-520.
16. Graeber M.B., Bise K., Mehraein P. CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropath. Appl. Neurobiol. 1994, 20:406-408.
17. Guidi S., Bonasoni P., Ceccarelli C., Santini D., Gualtieri F., Ciani E., Bartesaghi R. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol. 2008, 18:180-197.
18. Höftberger R., Fink S., Aboul-Enein F., Botond G., Olah J., Berki T., Ovadi J., Lassmann H., Budka H., Kovacs G.G. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis. Glia 2010, 58:1847-1857.
19. Hack M.A., Saghatelyan A., de Chevigny A., Pfeifer A., Ashery-Padan R., Lledo P.M., Gotz M. Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat. Neurosci. 2005, 8:865-872.
20. Haw C.M., Barnes T.R., Clark K., Crichton P., Kohen D. Movement disorder in Down's syndrome: a possible marker of the severity of mental handicap. Mov. Dis. 1996, 11:395-403.
21. Hlavanda E., Kovacs J., Olah J., Orosz F., Medzihradszky K.F., Ovadi J. Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations. Biochemistry 2002, 41:8657-8664.
22. Hutchins K.D., Dickson D.W., Rashbaum W.K., Lyman W.D. Localization of morphologically distinct microglial populations in the developing human fetal brain: implications for ontogeny. Brain Res. Dev. Brain Res. 1990, 55:95-102.
23. Jakovcevski I., Filipovic R., Mo Z., Rakic S., Zecevic N. Oligodendrocyte development and the onset of myelination in the human fetal brain. Front. Neuroanat. 2009, 3:5.
24. Khoshnood B., Greenlees R., Loane M., Dolk H. Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res. A. Clin. Mol. Teratol. 2011, 91(Suppl. 1):S16-S22.
25. Kitada M., Rowitch D.H. Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. Glia 2006, 54:35-46.
26. Kovacs G.G., Laszlo L., Kovacs J., Jensen P.H., Lindersson E., Botond G., Molnar T., Perczel A., Hudecz F., Mezo G., Erdei A., Tirian L., Lehotzky A., Gelpi E., Budka H., Ovadi J. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol. Dis. 2004, 17:155-162.
27. Kriegstein A., Alvarez-Buylla A. The glial nature of embryonic and stem cells. Annu. Rev. Neurosci. 2009, 32:149-184.
28. Larsen K.B., Laursen H., Graem N., Samuelsen G.B., Bogdanovic N., Pakkenberg B. Reduced cell number in the neocortical part of the human fetal brain in Down syndrome. Ann. Anat. 2008, 190:421-427.
29. Ligon K.L., Kesari S., Kitada M., Sun T., Arnett H.A., Alberta J.A., Anderson D.J., Stiles C.D., Rowitch D.H. Development of NG2 neural progenitor cells requires Olig gene function. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7853-7858.
30. Lu J., Lian G., Zhou H., Esposito G., Steardo L., Delli-Bovi L.C., Hecht J.L., Lu Q.R., Sheen V. OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors. Human Mol. Gen. 2012, 21:2330-2340.
31. Lu Q.R., Sun T., Zhu Z., Ma N., Garcia M., Stiles C.D., Rowitch D.H. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002, 109:75-86.
32. Maire C.L., Wegener A., Kerninon C., Nait Oumesmar B. Gain-of-function of Olig transcription factors enhances oligodendrogenesis and myelination. Stem cells 2010, 28:1611-1622.
33. Marshall C.A., Novitch B.G., Goldman J.E. Olig2 directs astrocyte and oligodendrocyte formation in postnatal subventricular zone cells. J. Neurosci. 2005, 25:7289-7298.
34. Menn B., Garcia-Verdugo J.M., Yaschine C., Gonzalez-Perez O., Rowitch D., Alvarez-Buylla A. Origin of oligodendrocytes in the subventricular zone of the adult brain. J. Neurosci. 2006, 26:7907-7918.
35. Nedergaard M., Ransom B., Goldman S.A. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003, 26:523-530.
36. Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., Giustetto M., Ferreira T.A., Guiducci E., Dumas L., Ragozzino D., Gross C.T. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333:1456-1458.
37. Parker S.E., Mai C.T., Canfield M.A., Rickard R., Wang Y., Meyer R.E., Anderson P., Mason C.A., Collins J.S., Kirby R.S., Correa A. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res. A Clin. Mol. Teratol. 2010, 88:1008-1016.
38. Rakic S., Zecevic N. Programmed cell death in the developing human telencephalon. Eur. J. Neurosci. 2000, 12:2721-2734.
39. Rezaie P., Dean A., Male D., Ulfig N. Microglia in the cerebral wall of the human telencephalon at second trimester. Cereb. Cortex 2005, 15:938-949.
40. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997, 20:570-577.
41. Ring H.A., Serra-Mestres J. Neuropsychiatry of the basal ganglia. J. Neurol. Neurosurg. Psych. 2002, 72:12-21.
42. Saijo K., Glass C.K. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 2011, 11:775-787.
43. Sierra A., Encinas J.M., Deudero J.J., Chancey J.H., Enikolopov G., Overstreet-Wadiche L.S., Tsirka S.E., Maletic-Savatic M. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010, 7:483-495.
44. Skjoerringe T., Lundvig D.M., Jensen P.H., Moos T. P25alpha/Tubulin polymerization promoting protein expression by myelinating oligodendrocytes of the developing rat brain. J. Neurochem. 2006, 99:333-342.
45. Stefanits H., Czech T., Pataraia E., Baumgartner C., Derhaschnig N., Slana A., Kovacs G.G. Prominent oligodendroglial response in surgical specimens of patients with temporal lobe epilepsy. Clin. Neuropathol. 2012, 31:409-417.
46. Takebayashi H., Nabeshima Y., Yoshida S., Chisaka O., Ikenaka K. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr. Biol. 2002, 12:1157-1163.
47. Takebayashi H., Yoshida S., Sugimori M., Kosako H., Kominami R., Nakafuku M., Nabeshima Y. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech. Devel. 2000, 99:143-148.
48. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., Gordon S. Macrophage receptors and immune recognition. Ann. Rev. Immunol. 2005, 23:901-944.
49. Tremblay M.E., Stevens B., Sierra A., Wake H., Bessis A., Nimmerjahn A. The role of microglia in the healthy brain. J. Neurosci. 2011, 31:16064-16069.
50. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science 2001, 291:657-661.
51. Vass K., Lassmann H. Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am. J. Pathol. 1990, 137:789-800.
52. Verney C., Monier A., Fallet-Bianco C., Gressens P. Early microglial colonization of the human forebrain and possible involvement in periventricular white-matter injury of preterm infants. J. Anat. 2010, 217:436-448.
53. Wierzba-Bobrowicz T., Lewandowska E., Schmidt-Sidor B., Gwiazda E. The comparison of microglia maturation in CNS of normal human fetuses and fetuses with Down's syndrome. Folia Neuropathol. 1999, 37:227-234.
54. Wisniewski K.E., Schmidt-Sidor B. Postnatal delay of myelin formation in brains from Down syndrome infants and children. Clin. Neuropathol. 1989, 8:55-62.
55. Wisniewski K.E., Wisniewski H.M., Wen G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 1985, 17:278-282.
56. Xue Q.S., Streit W.J. Microglial pathology in Down syndrome. Acta Neuropathol. 2011, 122:455-466.
57. Yue T., Xian K., Hurlock E., Xin M., Kernie S.G., Parada L.F., Lu Q.R. A critical role for dorsal progenitors in cortical myelination. J. Neurosci. 2006, t 26:1275-1280.
58. Zdaniuk G., Wierzba-Bobrowicz T., Szpak G.M., Stepien T. Astroglia disturbances during development of the central nervous system in fetuses with Down's syndrome. Folia Neuropathol. 2011, 49:109-114.
59. Zhou Q., Anderson D.J. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 2002, 109:61-73.